These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29897081)

  • 41. Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy.
    Zhang X; Lai D; Bao S; Hambly BD; Gillies MC
    Curr Mol Med; 2013 Jul; 13(6):946-58. PubMed ID: 23745583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats.
    Wang CF; Yuan JR; Qin D; Gu JF; Zhao BJ; Zhang L; Zhao D; Chen J; Hou XF; Yang N; Bu WQ; Wang J; Li C; Tian G; Dong ZB; Feng L; Jia XB
    J Ethnopharmacol; 2016 Jun; 185():162-70. PubMed ID: 26988565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
    Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
    Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
    [No Abstract]   [Full Text] [Related]  

  • 48. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
    Jonas JB; Söfker A; Degenring R
    Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the effect of intravitreal triamcinolone acetonide on diabetic macular edema dose-dependent?
    Šaric B; Šaric VB; Motušic R; Predovic J
    Eur J Ophthalmol; 2014; 24(2):221-7. PubMed ID: 24030541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catechin Weakens Diabetic Retinopathy by Inhibiting the Expression of NF-κB Signaling Pathway-Mediated Inflammatory Factors.
    Wang W; Zhang Y; Jin W; Xing Y; Yang A
    Ann Clin Lab Sci; 2018 Sep; 48(5):594-600. PubMed ID: 30373863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
    Jiang S; Chen X
    Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of apelin in the retina of diabetic rats.
    Lu Q; Feng J; Jiang YR
    PLoS One; 2013; 8(7):e69703. PubMed ID: 23874984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina.
    Creuzot-Garcher C; Acar N; Passemard M; Bidot S; Bron A; Bretillon L
    Retina; 2010 Sep; 30(8):1294-301. PubMed ID: 20526232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy.
    Galan A; Barcelona PF; Nedev H; Sarunic MV; Jian Y; Saragovi HU
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2852-2862. PubMed ID: 28570737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.
    Qiu AW; Liu QH; Wang JL
    Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
    Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
    Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-inflammatory role of sesamin in STZ induced mice model of diabetic retinopathy.
    Ahmad S; ElSherbiny NM; Jamal MS; Alzahrani FA; Haque R; Khan R; Zaidi SK; AlQahtani MH; Liou GI; Bhatia K
    J Neuroimmunol; 2016 Jun; 295-296():47-53. PubMed ID: 27235348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.